Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Esophageal Neoplasms × Itraconazole × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Basal Cell 3 Skin Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 2 gallium 68 PSMA-11 1 Oncolytic Virotherapy 1 Itraconazole 1 Fluorodeoxyglucose F18 1 Ferrosoferric Oxide 1 FAPI-46 1 Bevacizumab 1 68Ga-DKFZ-PSMA-11 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02749513 2021-11-04

Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

Dallas VA Medical Center

Phase EARLY_PHASE1 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡